BRIEF published on 04/30/2024 at 18:05, 2 years 5 months ago Breakthrough in Treatment for Macular Degeneration Blindness by Mesogen Inc. Biotechnology Healthcare Innovation Mesogen Inc Macular Degeneration Stem Cell Treatment
PRESS RELEASE published on 04/30/2024 at 18:00, 2 years 5 months ago Texas Company's Mission to Cure Macular Degeneration Blindness Mesogen Inc. from The Woodlands, Texas, developed a transplantable RPE patch for Macular Degeneration Blindness using autologous stem cells with no teratoma tumor risk Stem Cells Treatment Mesogen Inc. Macular Degeneration Blindness RPE Patch
Published on 10/26/2026 at 23:00, 39 minutes ago American Hotel Income Properties REIT LP to Host Third Quarter 2026 Results Conference Call on November 16, 2026
Published on 10/26/2026 at 22:00, 1 hour 39 minutes ago IBC Advanced Alloys Announces Issuance of Share-Based Compensation to Directors
Published on 10/26/2026 at 22:00, 1 hour 39 minutes ago Alset AI Announces Non-Brokered Private Placement Offering of a Minimum of $650,000 and a Maximum of $800,000
Published on 10/26/2026 at 21:30, 2 hours 9 minutes ago Clean Air Metals Announces Auditor Review of Q2 Financial Statements
Published on 10/26/2026 at 22:23, 1 hour 16 minutes ago EQS-Adhoc: SMAG Mobile Antenna Masts AG: Changes to the Management Board
Published on 10/26/2026 at 21:57, 1 hour 41 minutes ago EQS-Adhoc: PAUL Tech AG: Noteholders’ Meeting in respect of the EUR 35 million notes resolves on extension of the term of the notes
Published on 10/26/2026 at 21:32, 2 hours 6 minutes ago UPDATE ON STRATEGIC TRANSACTION, FURTHER PORTFOLIO DISPOSAL PROCESS AND CONTINUED LENDER SUPPORT
Published on 10/26/2026 at 20:00, 3 hours 39 minutes ago EQS-Adhoc: Hypoport SE: Gross profit growth and increase in EBIT in Q1-Q3 2026
Published on 10/26/2026 at 19:10, 4 hours 29 minutes ago PolyPeptide announces results of the extraordinary general meeting of shareholders
Published on 10/26/2026 at 18:11, 5 hours 28 minutes ago Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 17:30, 6 hours 9 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2026
Published on 10/26/2026 at 07:30, 16 hours 9 minutes ago EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/23/2026 at 20:33, 3 days 3 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
